News

The downside comes after PCVX reports mixed results from a mid-stage study on its pneumococcal vaccine in infants.
These findings provide mechanistic evidence linking neonatal antibiotic exposure to impaired vaccine immunogenicity via ...
The pneumococcal conjugate vaccine – codenamed PCV21/GBP410 – has started pivotal trials in the prevention of both paediatric Streptococcus pneumoniae, which remains a major public health ...
“Our data suggest that microbiota-targeted interventions could mitigate the detrimental effects of early-life antibiotics on ...
Sutro Biopharma, Inc.’s STRO share price has dipped by 5.51%, which has investors questioning if this is right time to buy.
The 15-valent conjugate vaccine was at least as effective ... Prior to COVID-19, pneumococcal vaccines were the largest vaccine market worldwide – estimated at around $8 billion – with Prevnar ...
How should continental vaccine manufacturers handle complex dynamics of supply and demand? ANALYSIS | The African Union has ...
Thrivent Financial for Lutherans acquired a new position in shares of Sutro Biopharma, Inc. (NASDAQ:STRO – Free Report) in the 4th quarter, according to its most recent filing with the Securities & ...
Before discussing pneumonia in children further, we must first know how the lungs work. In healthy lungs, oxygen enters when ...
Pneumococcal pneumonia is a potentially serious bacterial lung disease that can disrupt your life for weeks and even land you in the hospital. Medical experts want you to know that there are steps you ...
Market OverviewThe global Vaccines Market has evolved significantly in recent years, driven by advancements in biotechnology, ...
In addition to increasing vaccine coverage in older adults, they need to monitor the changing epidemiology of pneumococcal serotypes causing invasive disease. [134] In the face of these changes ...